ABSTRACT Background
Cardiovascular malformations have a higher incidence in patients with NF1 microdeletion syndrome compared to NF1 patients with intragenic mutation, presumably owing to haploinsufficiency of one or more genes included in the deletion interval and involved in heart development. In order to identify which genes could be responsible for cardiovascular malformations in the deleted patients, we carried out expression studies in mouse embryos and functional studies in zebrafish.
Methods and results
The expression analysis of three candidate genes included in the NF1 deletion interval, ADAP2, SUZ12 and UTP6, performed by in situ hybridization, showed the expression of ADAP2 murine ortholog in heart during fundamental phases of cardiac morphogenesis.
In order to investigate the role of ADAP2 in cardiac development, we performed loss-of-function experiments of zebrafish ADAP2 ortholog, adap2, by injecting two different morpholino oligos (adap2-MO and UTR-adap2-MO). adap2-MOs injected embryos (morphants) displayed in vivo circulatory and heart shape defects. The molecular characterization of morphants with cardiac specific markers showed that the injection of adap2-MOs causes defects in heart jogging and looping. In addition, morphological and molecular analysis of adap2 morphants demonstrated that the loss of adap2 function leads to defective valvulogenesis, suggesting a correlation between ADAP2 haploinsufficiency and the occurrence of valve defects in NF1-microdeleted patients.
Conclusions
Overall, our findings indicate that ADAP2 has a role in heart development and might be a reliable candidate gene for the occurrence of cardiovascular malformations in patients with NF1 microdeletion and, more generally, for the occurrence of a subset of congenital heart defects. by a more severe phenotype compared to the one observed in NF1 with intragenic mutation. [3] Comparing the clinical phenotype between NF1-microdeleted patients and the whole NF1 population, we found that cardiovascular malformations (CVMs) are significantly more frequent in NF1 patients with microdeletion syndrome than in those with neurofibromatosis caused by intragenic mutation. [4] The CMVs found in the NF1-deleted patients include pulmonic stenosis, atrial/ventricular septal defects and valve defects, and show an incidence of 18% versus 2.1%
displayed by NF1 patients with intragenic mutation. [4, 5] The higher incidence of CVMs in NF1-microdeleted patients is most likely dependent on the haploinsufficiency of genes lying in the deletion interval, presumably involved in heart morphogenesis. Our previous search for candidate genes by Northern blotting and RT-PCR analysis evidenced that three genes encompassed by NF1 microdeletion, SUZ12, ADAP2 (formerly CENTA2) and UTP6 (formerly C17ORF40) are highly expressed in human fetal heart and during the early developmental stages of mouse embryonic heart,[6] thus deserving further analysis.
SUZ12 (Suppressor of Zeste 12 Homolog (Drosophila)) is the human ortholog of the Drosophila
Su(z)12 polycomb gene, encoding a protein which is implicated in developmental mechanisms in Drosophila. [7] Mice lacking Suz12 are not viable and die around 7.5 days post coitum (dpc), displaying severe developmental and proliferative defects. [8] ADAP2 (ArfGAP with Dual PH domains 2) encodes a protein named Centaurin-alpha-2, which belongs to the centaurins protein family. Centaurin-alpha-2 is recruited to the plasma membrane where it specifically regulates actin cytoskeleton remodeling via ARF6, indicating an important role in exocytosis and cell motility. 
RESULTS

Expression analysis of Suz12, Utp6 and Adap2 genes in mouse reveals that Adap2 is Expressed During Key Stages of Heart Development
In order to elucidate the expression pattern of Suz12, Utp6 and Adap2 genes in mouse, we performed in situ hybridizations using whole mounts at different stages of development, ranging from 7.5 to 11.5 dpc.
The gene which revealed the most interesting expression pattern was Adap2, since it was visible in heart between 9 dpc and 10.5 dpc (figure 1) during fundamental phases of cardiac morphogenesis, namely heart looping (beginning at 8 dpc), endocardial cushion formation (10 dpc), and septation of the outflow tract, atria, and ventricles (10.5 dpc). In particular, the strongest Adap2 mRNA hybridization signal was seen in the heart atria and ventricles at 9.5 dpc ( figure 1E ), but its expression in the heart was visible as of 9 dpc ( figure 1C ) and was still present in both atria and ventricles at 10.5 dpc ( figure 1F ). We also performed in situ hybridizations on cryosections of 15.5 dpc embryos in order to assess if Adap2 transcript is also present in the heart during the later stages of fetal cardiac development. Our experiments demonstrated that the expression of Adap2 in the heart continues to be maintained at least until 15.5 dpc, in both the ventricles and atria ( figure 1H ).
Conversely, Suz12 evidenced a more spatially and temporally restricted expression in heart, with a clear hybridization signal only at 10.5 dpc in the atrium, while Utp6 revealed no expression in heart at any analyzed stages (figure S1).
Based on this evidence, we held ADAP2 the most interesting candidate gene for CVMs occurrence and we used zebrafish as a model organism to investigate in vivo its role during vertebrate heart development.
adap2, the ADAP2 Zebrafish Ortholog, is Required for Proper Cardiac Morphogenesis
In order to explore the spatio-temporal expression pattern of adap2, the ADAP2 zebrafish ortholog (Ensembl Gene ID: ENSDARG00000070565), we performed RT-PCR and whole mount in situ hybridization assays. adap2 transcript was detected by RT-PCR at all analyzed stages, from cleavage up to 120 hpf (hours post fertilization), as well as in the oocytes, indicating that the gene is both maternally and zygotically expressed. Furthermore, adap2 mRNA was present in all analyzed adult tissues, including heart (figure S2). Whole-mount in situ hybridization revealed that adap2 transcript was present in the heart at 2 dpf (days post fertilization) and 3 dpf stages, in the region corresponding to bulbus arteriosus (figure S2).
In order to investigate the potential role of adap2 during zebrafish heart development in vivo, we performed loss-of-function experiments by injecting two independent translation-blocking morpholinos (adap2-MO and UTR-adap2-MO) which target the region surrounding adap2 translation start codon and the 5'-UTR region, respectively. The injection of a control morpholino (std-MO) with no targets in zebrafish was used as control of the microinjection. At 2 dpf, most of embryos injected with 0.3 pmol of adap2-MO (morphants), unlike std-MO injected embryos, displayed blood circulation defects and curved tail (figure 2). Lower doses caused no circulatory defects. For the analysis of injected embryos, we focused our attention on 2 dpf, stage at which the circulation is surely started and the cardiac looping occurred in control embryos. At this stage, 61%
(n=94) of embryos injected with 0.3 pmol/embryo of adap2-MO showed one or more blood a  l  :  F  o  r  R  e  v  i  e  w  O  n  l  y circulatory defects, such as the total loss of circulation (21%), accumulation of blood cells in the trunk and/or tail region (48%) and blood stases in the head (13%) (figure 2D-F,G). All these circulatory defects were noticed in both adap2 morphants which showed a body axis comparable to that of control embryos and morphants which displayed a bent tail phenotype (71%, n=94). The injection of the second translation-blocking MO, UTR-adap2-MO, caused in vivo qualitatively similar defects to the first injected MO, though with a different penetrance ( figure S3 ).
To rule out that circulation defects could be caused by alterations of vascular development, we carried out adap2 loss-of-function experiments in the tg(flk1:EGFP) zebrafish transgenic line, [13] where EGFP expression is controlled by the endothelial specific flk1 promoter ( figure S4 ; figure   S5 ). At 2 dpf, adap2 knocked down embryos revealed no gross defects in vascular development, with correct development of main axial vessels, Dorsal Aorta (DA) and Cardinal Vein (CV), indicating a normal vasculogenesis. Weak defects in intersomitic vessels (Se) were observed only in those embryos with a marked curved tail, suggesting that these alterations were likely caused by structural defects of body axis rather than by angiogenesis abnormalities.
The evidence that two independent morpholinos gave the same in vivo phenotypes confirmed the specificity of the adap2 morpholinos. Consequently, we present here data obtained on embryos injected with the adap2-MO, which we indicate as adap2 morphants.
The evidence that circulatory defects in adap2 morphants were not caused by vascular defects suggested that they were most likely derived from an abnormal heart development and functionality. To test this hypothesis, we injected adap2-MO or std-MO in embryos belonging to the tg(gata1:dsRed) sd2 ;tg(flk1:EGFP) S843 double transgenic line, [14] in which erythrocytes are labeled in red and endothelial cells are labeled in green; we observed the injected embryos under a confocal microscope (figure 3). At 2 dpf, control embryos displayed a normal heart morphology (figure 3A), while adap2 morphants showed a reduction of atrioventricular (AV) canal bending, a partial lack of atrium and ventricle separation, as well as a reduced ventricle size (figure 3B-C). All analyzed embryos displayed blood circulation. figure 4A ). On the contrary, only 39% (n=59) of adap2-MO injected embryos displayed, at the same stage, the correct leftward cardiac jogging (figure 4B), while another 39% showed no jog, with the heart tube situated centrally along the midline of the embryo ( figure 4C ). Finally, the remaining 22% of adap2 morphants was characterized by an inverted cardiac jogging (right jog) (figure 4D). At 2 dpf, std-MO injected embryos hybridized with the cmlc2 specific probe presented a normal S-shaped heart with the ventricle positioned on the right of the atrium, indicating a correct D-looping process ( figure 4E ). Differently, only 22% (n=49)
of adap2 morphants showed a heart morphology comparable to control embryos ( figure 4F ). The histological sections of adap2 morphants at 5 dpf evidenced an endocardial detachment from the myocardial layer notably in the atrial chamber (figure 5F-G).
To characterize at molecular level the cardiac AV valve defects displayed by embryos as a consequence of adap2 functional inactivation we analyzed, by means of in situ hybridization experiments, the expression pattern of two markers, bmp4 (bone morphogenetic protein 4) and notch1b (notch homolog 1b), which at 2 dpf are specifically expressed within the myocardial and figure 6B ). Differently, 51% (n=41) of adap2-MO injected embryos displayed a disorganized and ectopically expanded bmp4 specific expression domain, notably as the ventricular chamber is concerned ( figure 6C-D) . These defects were observed in all the phenotypic classes of heart development. Similar results were obtained from the analysis of notch1b marker at the same stage, with 49% (n=43) of adap2-MO injected embryos displaying an expanded and disorganized notch1b expression pattern (figure 6G-H). All these data highlight adap2 function in fundamental processes of zebrafish cardiac morphogenesis, notably heart jogging, heart looping, determination of ventricular size and AV valve formation.
Overall, our findings provide compelling evidence that ADAP2 is involved in heart development, pointing to it as the most plausible candidate gene for the occurrence of congenital CVMs in NF1 microdeletion syndrome and, more generally, for the occurrence of sporadic and familial congenital CVMs. mutations. [3] By reviewing the phenotype of 92 patients with NF1 microdeletion, we found that CVMs occurred at a significantly higher incidence in this patient population as compared to NF1 Here, we analyzed the spatio-temporal expression profile of the above mentioned genes during mouse embryonic and fetal development. Based on this analysis, Adap2 seems to be expressed in heart starting from 9 dpc, during key phases of cardiac development, that is when the heart tube is elongating and looping, and atrial and ventricular septa, as well as AV valves, are forming.
DISCUSSION
[16]
Moreover, Adap2 expression in heart continues even in the later stages of development, at least until 15.5 dpc. Of note, Adap2 expression is not restricted to a particular cardiac compartment or structure, but rather seems to localize in both atria and ventricles. Suz12 was also detected in heart during mouse development, but its expression seems to be restricted to a short period around 10.5 dpc and to the heart atria. Differently, Utp6 showed no expression in the developing heart at all.
Since the expression of ADAP2 mouse ortholog in heart during fundamental stages of cardiac morphogenesis was suggestive of a role in heart development, we studied the possible role of ADAP2 in heart development by employing zebrafish as a model system. Over the recent years, zebrafish has proven to be a valid model for studying cardiovascular development. Despite its apparent simplicity, the zebrafish heart shares common structural, developmental and genetics features with avian and mammalian heart.[17-19] In addition, because of their small size, they receive enough oxygen by passive diffusion from external medium to survive and continue to develop in a relatively normal fashion for several days even in the complete absence of blood circulation, allowing a detailed phenotypic analysis of animals with severe cardiovascular defects that would be lethal in other organisms.
[20]
The functional inactivation of adap2, the ADAP2 zebrafish ortholog, obtained by the injection of two MO oligos targeting different adap2 mRNA regions (translation start site and 5'-UTR), caused the same circulatory defects, proving the specificity of the phenotypes. We also designed a splice- Our molecular results suggested adap2 involvement in the cardiac jogging process, the morphogenetic process in which the heart cone is displaced to the left with respect to the anteriorposterior axis, which is one of the first evident breaks in left-right symmetry of the primitive zebrafish heart tube.
[21] Moreover, adap2 also appeared fundamental for the subsequent D-looping process, the bend of the heart tube to the right, which by 36 hpf leads to the typical S-shaped heart, with the ventricle positioned on the right of the atrium. This was supported by the high number of adap2 morphants which at 2 dpf, when D-looping is normally completed, showed a linear heart, a reduced loop or a reversed loop, all defects ascribable to alterations of the heart bending taking place during the D-looping process.
Functional inactivation of adap2 also evidenced its important role during AV valve morphogenesis, since the earliest stages of endocardial cushion formation. Our results strongly suggest that a defective valvulogenesis results in impaired cardiac functionality, therefore AV valve morphological alterations are most likely accounting for the in vivo blood circulation defects displayed by adap2 morphants. Valve defects, including mitral valve prolapse, pulmonary valve stenosis and aortic valve anomalies, constitute a significant proportion of CVMs observed in patients with NF1 microdeletion syndrome. [3, 4] Taking into account our findings on ADAP2 role in valve morphogenesis, a correlation between ADAP2 haploinsufficiency and the onset of valvular defects in NF1-microdeleted patients can be hypothesized. In addition, the detachment between During the early phases of valve morphogenesis, the myocardial component of AV junction is fundamental for the signaling events leading endocardial cells to begin the formation of cushions, which will be later remodeled to create flap-like valvular structures.
[23] The marked alteration of bmp4 myocardial expression in adap2 morphants suggests a compromised signaling from myocardium to endocardium, which might result in the structural valve defects observed at 5 dpf.
Overall, our study points to ADAP2 as a gene involved in heart development and as a plausible candidate gene for the occurrence of CVMs in NF1-microdeleted patients and in the general population, constituting an advance towards a better comprehension of the complex phenotypic spectrum of the syndrome, as well as of the genetic basis of CVMs. 
MATERIALS AND METHODS
Animals
RT-PCR
RT-PCR was performed on total RNA extracted from oocytes, embryos (about 30 embryos per sample) at different developmental stages and adult organs using the TOTALLY RNA isolation kit (Ambion), treated with RQ1 RNase-Free DNase (Promega) and oligo(dT)-reverse transcribed using
Super-Script II RT (Invitrogen), according to manufacturers' instructions. The following primers were used for PCR reactions: adap2_fw 5'-GCTTAGACTTCTGGGATG-3', adap2_rev 5'-CGAGATAACGGTTTTCAAGGC-3'. PCR products were loaded and resolved onto 2% agarose gels.
In Situ Hybridization
Probes were isolated by RT-PCR using specific primers ( Images of stained embryos were taken with a Leica MZFLIII epifluorescence stereomicroscope equipped with a DFC 480 digital camera and IM50 Leica imaging software (Leica).
For histological sections, stained embryos were re-fixed in 4% PFA, dehydrated, wax embedded, sectioned (8 µm) by a microtome (Leitz 1516) and stained with eosin. Images were taken with an Olympus BH2 microscope, equipped with a Leica DFC 320 digital camera and the IM50 software (Leica).
Morpholino Injections and Phenotype Analysis
Antisense morpholinos (MOs; Gene Tools) were designed against the AUG translation start site region and the coding sequence, adap2-MO (5'-TTGTTCTTTTCCCGATTTGCCATAG-3') and against the 5'-UTR region, UTR-adap2-MO (5'-AAAACACTCCTGTCGCGTCAGAATC-3'). As a control for unspecific effects, each experiment was performed in parallel with a std-MO (standard control oligo) with no target in zebrafish.
All morpholinos were diluted in Danieau solution [33] and injected at 1-2 cells stage. Rhodamine dextran (Molecular Probes) was usually co-injected as a tracer. After injection, embryos were raised in fish water at 28ºC and observed up to the stage of interest. For a better observation, the injected embryos were anaesthetized using 0.016% tricaine (Ethyl 3-aminobenzoate methanesulfonate salt, SIGMA) in fish water. for EGFP and blocking filter LP 590 for ds Red).
For histological analysis 3 dpf and 5 dpf zebrafish early larvae were fixed overnight at 4°C with bouin fixative. The samples were then dehydrated in a graded ethanol series, wax embedded, sectioned (8 µm) by a microtome (Leitz 1516) and stained with hematoxylin/eosin. Images were taken with a Leica DM6000 B microscope equipped with a Leica DCF480 digital camera and the LAS software.
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